.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Teva
Dow
Farmers Insurance
Baxter
Accenture
Daiichi Sankyo
Boehringer Ingelheim
Cantor Fitzgerald

Generated: December 12, 2017

DrugPatentWatch Database Preview

Fosinopril sodium; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fosinopril sodium; hydrochlorothiazide and what is the scope of fosinopril sodium; hydrochlorothiazide freedom to operate?

Fosinopril sodium; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Aurobindo Pharma, Emcure Pharms India, Invagen Pharms, Mylan, Sandoz, Sun Pharm Inds Ltd, Teva, Watson Labs, and Bristol Myers Squibb, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium; hydrochlorothiazide. Eight suppliers are listed for this compound.

Summary for fosinopril sodium; hydrochlorothiazide

Pharmacology for fosinopril sodium; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms IndiaFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL079025-002Sep 17, 2010ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL076608-002Dec 3, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL077705-001Aug 14, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo PharmaFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL079245-001Jul 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL076739-001Dec 17, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL076961-002Sep 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL076945-002Jul 5, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL076608-001Dec 3, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL076739-002Dec 17, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsFOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDEfosinopril sodium; hydrochlorothiazideTABLET;ORAL077144-002Aug 16, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fosinopril sodium; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers SquibbMONOPRIL-HCTfosinopril sodium; hydrochlorothiazideTABLET;ORAL020286-002Nov 30, 1994► Subscribe► Subscribe
Bristol Myers SquibbMONOPRIL-HCTfosinopril sodium; hydrochlorothiazideTABLET;ORAL020286-001Nov 30, 1994► Subscribe► Subscribe
Bristol Myers SquibbMONOPRIL-HCTfosinopril sodium; hydrochlorothiazideTABLET;ORAL020286-001Nov 30, 1994► Subscribe► Subscribe
Bristol Myers SquibbMONOPRIL-HCTfosinopril sodium; hydrochlorothiazideTABLET;ORAL020286-001Nov 30, 1994► Subscribe► Subscribe
Bristol Myers SquibbMONOPRIL-HCTfosinopril sodium; hydrochlorothiazideTABLET;ORAL020286-002Nov 30, 1994► Subscribe► Subscribe
Bristol Myers SquibbMONOPRIL-HCTfosinopril sodium; hydrochlorothiazideTABLET;ORAL020286-002Nov 30, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Covington
Federal Trade Commission
Deloitte
Cantor Fitzgerald
Cipla
Fuji
Baxter
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot